Publishing research using ab213524? Please let us know so that we can cite the reference in this datasheet.

ab213524 has been referenced in 5 publications.

  • Chen Y  et al. Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation. Oncol Rep 40:3370-3380 (2018). PubMed: 30272332
  • Liu Y  et al. PD-1 blockade inhibits lymphocyte apoptosis and restores proliferation and anti-viral immune functions of lymphocyte after CP and NCP BVDV infection in vitro. Vet Microbiol 226:74-80 (2018). PubMed: 30389046
  • Zhang W  et al. Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer. Transl Oncol 12:485-492 (2018). PubMed: 30594037
  • Horita H  et al. Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton. Neoplasia 19:346-353 (2017). WB ; Human . PubMed: 28319808
  • Zhou ZH  et al. The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer. J Cancer Res Clin Oncol N/A:N/A (2017). IHC ; Human . PubMed: 28180998

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up